Teenagers and young adults with cancer need better access to clinical trials

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1959 (Published 25 March 2013)
Cite this as: BMJ 2013;346:f1959

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Zosia Kmietowicz
  1. 1BMJ

The number of teenagers and young adults dying from cancer in the United Kingdom has halved since the 1970s, show figures in a new report. But clinicians have said that too few people in this age group are being enrolled in clinical trials and that the development of new treatments has been poor as a result.

The report from Cancer Research UK said that each year cancer is diagnosed in around 2200 young people aged between 15 and 24 years and that around 310 die from it, down from about 580 deaths a year in the mid-1970s.1

The death rate from cancer in teenagers and young adults fell from 74.5 per million …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL